Lumito AB (publ) (NGM:LUMITO)

Sweden flag Sweden · Delayed Price · Currency is SEK
2.970
-0.130 (-4.19%)
At close: May 8, 2026
Market Cap10.22M -90.4%
Revenue (ttm)n/a
Net Income-43.94M
EPS-43.23
Shares Out3.44M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,523
Average Volume16,230
Openn/a
Previous Close3.100
Day's Rangen/a
52-Week Range2.970 - 348.500
Beta0.60
RSI33.02
Earnings DateMay 11, 2026

About Lumito AB

Lumito AB (publ) engages in the medical research and development of imaging technology in Sweden. It offers tissue analysis system based on upconverting nanoparticles, including SCIZYS system combining labeling and imaging technologies to locate and measure biomarkers in tissue samples. The company’s technology addresses challenges in various application areas, such as drug development, academic research, and clinical diagnostics. Lumito AB (publ) was incorporated in 2010 and is headquartered in Lund, Sweden. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2010
Employees 8
Stock Exchange Nordic Growth Market
Ticker Symbol LUMITO
Full Company Profile

Financial Performance

Financial Statements

News

Lumito AB Transcript: Life Science Summit 2025

A new tissue diagnostics platform aims to reduce subjectivity and human error using nanoparticle technology, targeting a $1.8 billion global market. Early commercialization is underway with CRO partnerships, and expansion is prioritized in Europe before North America.

6 months ago - Transcripts